MDR Charting, page-127

Sorry Pinto but unfortunately that's all I know at this stage. Maybe @bonkers89 could ask management when he meets them

Bonkers can you ask them a question for me? We know that this app has the potential to save our health system an astronomical amount of money. To them, it's all about the benefit-cost ratio. Is it worth spending x amount by subsidising this new drug for diabetes if it saves us from y people developing uncontrolled diabetes and ending up in hospital to have their foot amputated? Pharmacies actually currently receive a small incentive from Medicare for packing Webster packs for patients because this increases patient compliance.

The question is: have management been in talks with the Department of Health? How do they think they could work collaboratively to encourage the use of Medadvisor (e.g. pharmacies which use Medadvisor receving a small reimbursement, patients from public hospitals also being discharged with the app)?

Thanks